Age-related macular degeneration.
作者信息
Ayoub Tariq, Patel Nishal
机构信息
Guys & St Thomas NHS Trust Westminster Bridge Road, London SE1 7EH.
出版信息
J R Soc Med. 2009 Feb;102(2):56-61. doi: 10.1258/jrsm.2009.080298.
Abstract
摘要
相似文献
1
Age-related macular degeneration.年龄相关性黄斑变性
J R Soc Med. 2009 Feb;102(2):56-61. doi: 10.1258/jrsm.2009.080298.
2
Age-related macular degeneration.年龄相关性黄斑变性
Br J Hosp Med (Lond). 2005 Dec;66(12):677-81. doi: 10.12968/hmed.2005.66.12.20206.
3
Age-Related Macular Degeneration.年龄相关性黄斑变性
Prim Care. 2015 Sep;42(3):377-91. doi: 10.1016/j.pop.2015.05.009.
4
Age-related macular degeneration.年龄相关性黄斑变性
Ulster Med J. 2005 Sep;74(2):82-92.
5
[New therapeutic aspects in age-related macular degeneration].[年龄相关性黄斑变性的新治疗方面]
Med Clin (Barc). 2007 Nov 10;129(17):658-9. doi: 10.1157/13112103.
6
Age-related macular degeneration.年龄相关性黄斑变性
Postgrad Med J. 1998 Apr;74(870):203-7. doi: 10.1136/pgmj.74.870.203.
7
Age-related macular degeneration: evaluation and treatment.年龄相关性黄斑变性：评估与治疗
Cleve Clin J Med. 2003 Dec;70(12):1017-8, 1020, 1023-5 passim. doi: 10.3949/ccjm.70.12.1017.
8
[Degenerative maculopathy (in younger patients)].[变性性黄斑病变（年轻患者中）]
Klin Monbl Augenheilkd. 2014 Dec;231(12):1239-55. doi: 10.1055/s-0033-1358018. Epub 2014 Nov 13.
9
[Age-related macular degeneration. The Danish Society of Ophthalmology].[年龄相关性黄斑变性。丹麦眼科学会]
Ugeskr Laeger. 2006 Mar 20;168(12):1235.
10
[2/6--Age-related macular degeneration].[2/6 - 年龄相关性黄斑变性]
Soins Gerontol. 2009 Mar-Apr(76):45-6.
引用本文的文献
1
Can artificial intelligence with multimodal imaging outperform traditional methods in predicting age-related macular degeneration progression? A systematic review and exploratory meta-analysis.具有多模态成像的人工智能在预测年龄相关性黄斑变性进展方面能否优于传统方法？一项系统评价和探索性荟萃分析。
BMC Med Inform Decis Mak. 2025 Sep 1;25(1):321. doi: 10.1186/s12911-025-03119-z.
2
Neutrophils in Ocular Diseases.眼疾中性粒细胞。
Int J Mol Sci. 2024 Jul 15;25(14):7736. doi: 10.3390/ijms25147736.
3
AMD and Stem Cell-Based Therapies.AMD 与基于干细胞的疗法。
Int Ophthalmol Clin. 2024 Jan 1;64(1):21-33. doi: 10.1097/IIO.0000000000000510. Epub 2023 Dec 26.
4
One-Year and 18-Month Outcomes in nAMD Patient Eyes Switched to Brolucizumab Alone versus to Brolucizumab Alternating with Other Anti-VEGF Agents.湿性年龄相关性黄斑变性（nAMD）患者的患眼单独改用布罗珠单抗与布罗珠单抗与其他抗血管内皮生长因子（VEGF）药物交替使用的1年和18个月疗效
Clin Ophthalmol. 2023 Nov 23;17:3601-3611. doi: 10.2147/OPTH.S432957. eCollection 2023.
5
An Analysis of the Usage of Retinal Imaging Technology in the Detection of Age-Related Macular Degeneration.视网膜成像技术在年龄相关性黄斑变性检测中的应用分析
Cureus. 2023 Jun 16;15(6):e40527. doi: 10.7759/cureus.40527. eCollection 2023 Jun.
6
Drusen-aware model for age-related macular degeneration recognition.基于 年龄相关性黄斑变性识别的 渗出物感知模型。
Ophthalmic Physiol Opt. 2023 Jul;43(4):668-679. doi: 10.1111/opo.13108. Epub 2023 Feb 14.
7
Multimodal Genotype and Phenotype Data Integration to Improve Partial Data-Based Longitudinal Prediction.多模态基因型和表型数据的整合，以提高基于部分数据的纵向预测。
J Comput Biol. 2022 Dec;29(12):1324-1345. doi: 10.1089/cmb.2022.0378. Epub 2022 Nov 16.
8
Mouse Pharmacokinetics and In Vitro Metabolism of SH-11037 and SH-11008, Synthetic Homoisoflavonoids for Retinal Neovascularization.用于视网膜新生血管形成的合成高异黄酮SH-11037和SH-11008的小鼠药代动力学及体外代谢
Pharmaceutics. 2022 Oct 24;14(11):2270. doi: 10.3390/pharmaceutics14112270.
9
Consequences of a Rare Complement Factor H Variant for Age-Related Macular Degeneration in the Amish.罕见补体因子 H 变异与阿什肯纳兹人群年龄相关性黄斑变性的关系。
Invest Ophthalmol Vis Sci. 2022 Aug 2;63(9):8. doi: 10.1167/iovs.63.9.8.
10
Findings of uncertain significance by optical coherence tomography (OCT) as prognostic factors in neovascular age-related macular degeneration (nAMD) treated with ranibizumab.在接受雷珠单抗治疗的新生血管性年龄相关性黄斑变性（nAMD）中，光学相干断层扫描（OCT）发现的意义不确定的结果作为预后因素。
Int J Retina Vitreous. 2022 Apr 21;8(1):29. doi: 10.1186/s40942-022-00379-z.
本文引用的文献
1
Age-related macular degeneration: an update on treatment.年龄相关性黄斑变性：治疗进展
Am J Med. 2008 Apr;121(4):279-81. doi: 10.1016/j.amjmed.2007.10.020.
2
Ranibizumab combined with verteporfin photodynamic therapy in neovascular age-related macular degeneration (FOCUS): year 2 results.雷珠单抗联合维替泊芬光动力疗法治疗新生血管性年龄相关性黄斑变性（FOCUS）：2年结果
Am J Ophthalmol. 2008 May;145(5):862-74. doi: 10.1016/j.ajo.2007.12.029. Epub 2008 Mar 5.
3
Delivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriers.用于治疗增殖性玻璃体视网膜病变的递送系统：材料、装置和胶体载体
Curr Drug Deliv. 2008 Jan;5(1):7-19. doi: 10.2174/156720108783331050.
4
Haplotypes in the complement factor H (CFH) gene: associations with drusen and advanced age-related macular degeneration.补体因子H（CFH）基因中的单倍型：与玻璃膜疣及晚期年龄相关性黄斑变性的关联
PLoS One. 2007 Nov 28;2(11):e1197. doi: 10.1371/journal.pone.0001197.
5
Dietary antioxidants and primary prevention of age related macular degeneration: systematic review and meta-analysis.膳食抗氧化剂与年龄相关性黄斑变性的一级预防：系统评价与荟萃分析
BMJ. 2007 Oct 13;335(7623):755. doi: 10.1136/bmj.39350.500428.47. Epub 2007 Oct 8.
6
Novel approaches to retinal drug delivery.视网膜药物递送的新方法。
Expert Opin Drug Deliv. 2007 Jul;4(4):371-88. doi: 10.1517/17425247.4.4.371.
7
Photodynamic therapy for neovascular age-related macular degeneration.光动力疗法治疗新生血管性年龄相关性黄斑变性
Cochrane Database Syst Rev. 2007 Jul 18(3):CD002030. doi: 10.1002/14651858.CD002030.pub3.
8
Avastin and new treatments for AMD: where are we?阿瓦斯汀与年龄相关性黄斑变性的新疗法：我们进展到哪一步了？
Retina. 2006 Oct;26(8):853-8. doi: 10.1097/01.iae.0000244722.35073.7c.
9
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.雷珠单抗与维替泊芬治疗新生血管性年龄相关性黄斑变性的比较。
N Engl J Med. 2006 Oct 5;355(14):1432-44. doi: 10.1056/NEJMoa062655.
10
Ranibizumab for neovascular age-related macular degeneration.雷珠单抗用于治疗新生血管性年龄相关性黄斑变性。
N Engl J Med. 2006 Oct 5;355(14):1419-31. doi: 10.1056/NEJMoa054481.
Zotero 插件